CHMP5 and COVID-19: Thus, SARS-CoV-2-specific T cell responses (against the Spike (S) and Membrane (M) protein) were found significantly less frequently in immunocompromised patients, who are considered particularly at risk of severe forms of COVID-19 [20,21].